Tropical Parasitic

Product Price :Get Latest Price

Product Details:

This test is intended to be used for the qualitative detection of IgM anti-dengue viruses (DEN1,2,3,4) in human serum or plasma. It is intended to be used by professionals as an aid in the diagnosis of acute dengue infection. Any interpretation or use of this test result must also rely on other clinical findings as well as on the professional judgment of healthcare providers. During primary infection, anti-dengue IgM antibodies start to appear approximately 4-6 days after the onset of fever, peak at about 2 weeks, and remain in circulation for about 2-3 months.  During secondary infection, IgM antibodies increase simultaneously with, or after the IgG antibody response, in general at a titer lower than IgG. Importantly, IgM antibody levels during secondary infection are significantly lower in comparison with primary infection.

The three main kit components are:

• A 96 breakable well plate with the solid microwells pre-coated with mouse monoclonal anti-human IgM antibody
• Recombinant dengue antigen
• HRP-anti-dengue  conjugates

Recommended for use:

• Any person presenting with clinical signs or symptoms consistent with acute dengue infection or dengue fever including: High fever, severe headaches, pain behind the eyes, severe joint and muscle pain, fatigue, nausea, vomiting, and/or skin rash.

Features:

• SeraCare AccuSet Performance Panel (0845-0051): 100% agreement with a market leading Dengue IgM Capture ELISA
• Cross Reactivity: No cross reaction with CHIK, HCV, Syphilis, HBsAg, ANA, HIV, HAMA, H. pylori, RF, Malaria
• Interference: No interference with substances: Salicylic acid: 4.34 mmol/L; Glucose: 55 mmol/L; Sodium citrate: 1.3 %;Heparin: 3,000 U/L;  Creatinine:  442 μmol/L; Bilirubin:  10 mg/dL; EDTA: 3.4 μmol/L
• Intra Assay Precision: CV: <7%
• Inter Assay Precision: CV: <10%
• Anti-human IgM coated microwells
• Lyophilized dengue antigen
• HRP-anti-dengue conjugates (100X concentrate)
• Enzyme diluent
• Dengue IgM positive control
• Dengue IgM negative control
• Sample diluent
• Wash buffer (30X concentrate)
• TMB substrate A
• TMB substrate B
• Stop solution
• ELISA working sheet
• Product insert

Product Price :Get Latest Price

Product Details:

This test is intended to be used for the qualitative detection of IgG anti-dengue viruses (DEN1,2,3,4) in human serum or plasma. It is intended to be used by professionals as an aid in the diagnosis of active infection with dengue viruses, including secondary infection.  Any interpretation or use of this test result must also rely on other clinical findings as well as on the professional judgment of health care providers. During primary infection, anti-dengue IgG antibodies become detectable by the end of the first week of illness. They increase slowly to peak around 14-21 days, and then decrease to low levels, persisting for the duration of life.  During secondary infection, a strong and rapid IgG antibody response is often observed.  IgG levels are detectable as early as 3 days after the onset of symptoms, with the peak detection window being  1-2 weeks after symptom onset. In secondary infection, IgG antibodies rise to levels higher than during primary infection. Importantly, anti-dengue IgG antibodies increase earlier than or simultaneously with IgM antibodies, and at much higher levels during secondary infection.

The three main kit components are:

• A 96 breakable well plate with the solid microwells pre-coated with mouse monoclonal anti-human IgG antibody
• Recombinant dengue antigen
• HRP-anti-dengue conjugates

 

Recommended for use:

• Any person presenting with clinical signs or symptoms consistent with acute dengue infection or dengue fever including: High fever, severe headaches, pain behind the eyes, severe joint and muscle pain, fatigue, nausea, vomiting, and/or skin rash.

Features:

• SeraCare AccuSet Performance Panel (0845-0051): 100% agreement with a market leading Dengue IgG Capture ELISA
• Cross Reactivity: No cross reaction with HCV, Syphilis, HBsAg, ANA, HIV, HAMA, H. pylori, RF, Malaria
• Interference: No interference with Salicylic acid: 4.34 mmol/L; Glucose: 55 mmol/L; Sodium citrate: 1.3 %;Heparin: 3,000 U/L;  Creatinine:  5 mmol/L; Bilirubin:  10 mg/dL; EDTA: 3.4 μmol/L
• Intra Assay Precision: CV < 7%
• Inter Assay Precision: CV < 6%
• Anti-human IgG coated microwells
• Lyophilized dengue antigen
• HRP-anti-dengue conjugates (100X concentrate)
• Enzyme diluent
• Dengue IgG positive control
• Dengue IgG negative control
• Sample diluent
• Wash buffer (30X concentrate)
• TMB substrate A
• TMB substrate B
• Stop solution
• ELISA working sheet
• Product insert

Product Price :Get Latest Price

Product Details:

This test is intended for the qualitative detection of dengue NS1 antigen (DEN1, 2, 3, 4) in human serum or plasma. It is intended to be used by professionals as an aid in the early detection of dengue virus infection. Any interpretation or use of this test result must also rely on other clinical findings as well as on the professional judgment of healthcare providers. Dengue NS1 antigen is released into the blood during viral replication in an infected patient, and is detectable from the first day after the onset of fever up to Day 9. NS1 antigen can be identified before the formation of antibodies, thus making it a beneficial biomarker for early detection of dengue infection, allowing for prompt management of dengue fever.

The two main kit components are:

• A 96 breakable well plate with the solid microwells pre-coated with rabbit anti- Pan Dengue NS1 antibody
• A conjugate solution composed of antibodies against Dengue NS1 antigen conjugated with horseradish peroxidase (HRP-anti-dengue NS1 conjugates)

 

Recommended for use:

• Any person presenting with clinical signs or symptoms consistent with acute dengue infection or dengue fever including: High fever, severe headaches, pain behind the eyes, severe joint and muscle pain, fatigue, nausea, vomiting, and/or skin rash

Features:

• Analytic sensitivity: Detects recombinant Dengue type 2 NS1 at a level as low as 0.3 ng/mL.
• SeraCare Dengue Early Infection AccuSet Performance Panel: 100% agreement with PanBio Dengue Early ELISA
• Cross Reactivity: No cross reaction with HCV, Syphilis, HBsAg, ANA, HIV, HAMA, H. pylori, RF, Malaria
• Hook Effect: No hook effect up to 0.1 mg/mL
• Interference: No interference with Salicylic acid: 4.34 mmol/L; Glucose: 55 mmol/L; Sodium citrate: 1.3 %;Heparin: 3,000 U/L; Creatinine: 5 mmol/L; Bilirubin: 10 mg/dL; EDTA: 3.4 μmol/L
• Intra Assay Precision: CV < 10%
• Inter Assay Precision: CV < 7%
• Anti-dengue NS1 Ab coated microwells
• HRP–anti-dengue NS1 conjugates
• Dengue NS1 Antigen positive control
• Dengue NS1 Antigen negative control
• Wash buffer (30X Concentrate)
• Sample diluent
• TMB substrate A
• TMB substrate B
• Stop solution
• ELISA working sheet
• Product insert

Product Price :Get Latest Price

Product Details:

The RecombiLISA CHIK IgM ELISA Kit is a solid phase enzyme-linked immunosorbent assay for the qualitative detection of IgM anti-Chikungunya virus in human serum or plasma.

 

Features:

• Microwells coated with recombinant CHIK antigens
• Sample diluent
• HRP–anti-human IgM conjugate
• Wash buffer (30 x concentrate)
• Stop solution
• ELISA working sheet
• Product insert

Product Price :Get Latest Price

Product Details:

The RecombiLISA Chagas IgG ELISA Kit is solid phase enzyme-linked immunosorbent assay for the qualitative detection of IgG to Trypanosoma cruzi (T. cruzi) in human serum or plasma. The transmission of transfusion is a recognized risk; can be used as a blood bank screening tool.

 

Features:

• Utilizes recombinant antigens to improve sensitivity in comparison with native antigen based tests
• 100% sensitivity and specificity against BBI panel
• Adaptable to fully automated systems
• Microwells coated with recombinant T. cruzi antigens
• Chagas IgG positive control
• Chagas IgG negative control
• Sample diluent
• HRP–anti human IgG conjugates
• Wash buffer (30 x concentrate)
• Stop solution
• ELISA working sheet
• Product insert